{"title":"A cluster double-crossover trial of early versus delayed aperient use in mechanically ventilated, enterally fed patients","authors":"Yaodong Tang MMed FCICM , Glenn Eastwood RN PHD , Nuanprae Kitisin MD , Nuttapol Pattamin MD , Yukiko Hikasa MD , Jonathan Nübel MD , Alessandro Caroli MD , Stephen Warrillow PHD FRACP FCICM , Rinaldo Bellomo PHD FRACP FCICM , Ary Serpa Neto PHD FCICM","doi":"10.1016/j.aucc.2025.101300","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Aperient use in enterally fed, intubated, invasively mechanically ventilated intensive care unit (ICU) patients remains controversial and is associated with diarrhoea. The aim of this study was to assess whether the timing of aperient administration impacts the incidence and timing of diarrhoea and related complications in such patients.</div></div><div><h3>Methods</h3><div>We conducted a cluster, double-crossover, randomised trial in mechanically ventilated, enterally fed adults. We compared “delayed” aperient use (started on day 6 of enteral feeding) to “early” aperient use (started on day 1 of enteral feeding). The primary outcome was the occurrence of diarrhoea. Secondary outcomes included time until first defecation, rate of faecal management device insertion, rate of ileus, ICU length of stay, and mortality. Data were analysed using a Bayesian analysis.</div></div><div><h3>Results</h3><div>Of the 177 patients included, 42.4% in the delayed aperient group and 44.9% in early group developed diarrhoea (odds ratio: 0.91 [95% credible interval: 0.52 to 1.61]; probability of benefit: 62.4%). Diarrhoea, however, occurred later in patients in the delayed aperient group. Moreover, the occurrence of diarrhoea after day 6 was less in the delayed aperients group (21.2% vs. 44.9%; odds ratio: 0.37 [95% credible interval: 0.20 to 0.68]; probability of benefit: 99.9%). Other secondary outcomes including rate of ileus, ICU length of stay, and mortality did not show significant difference.</div></div><div><h3>Conclusion</h3><div>The timing of aperient administration did not impact the occurrence of diarrhoea or other patient-centred outcomes but delayed its onset. These findings suggest that delaying aperients has limited impact on diarrhoea.</div></div>","PeriodicalId":51239,"journal":{"name":"Australian Critical Care","volume":"38 5","pages":"Article 101300"},"PeriodicalIF":2.7000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australian Critical Care","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1036731425001304","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Aperient use in enterally fed, intubated, invasively mechanically ventilated intensive care unit (ICU) patients remains controversial and is associated with diarrhoea. The aim of this study was to assess whether the timing of aperient administration impacts the incidence and timing of diarrhoea and related complications in such patients.
Methods
We conducted a cluster, double-crossover, randomised trial in mechanically ventilated, enterally fed adults. We compared “delayed” aperient use (started on day 6 of enteral feeding) to “early” aperient use (started on day 1 of enteral feeding). The primary outcome was the occurrence of diarrhoea. Secondary outcomes included time until first defecation, rate of faecal management device insertion, rate of ileus, ICU length of stay, and mortality. Data were analysed using a Bayesian analysis.
Results
Of the 177 patients included, 42.4% in the delayed aperient group and 44.9% in early group developed diarrhoea (odds ratio: 0.91 [95% credible interval: 0.52 to 1.61]; probability of benefit: 62.4%). Diarrhoea, however, occurred later in patients in the delayed aperient group. Moreover, the occurrence of diarrhoea after day 6 was less in the delayed aperients group (21.2% vs. 44.9%; odds ratio: 0.37 [95% credible interval: 0.20 to 0.68]; probability of benefit: 99.9%). Other secondary outcomes including rate of ileus, ICU length of stay, and mortality did not show significant difference.
Conclusion
The timing of aperient administration did not impact the occurrence of diarrhoea or other patient-centred outcomes but delayed its onset. These findings suggest that delaying aperients has limited impact on diarrhoea.
期刊介绍:
Australian Critical Care is the official journal of the Australian College of Critical Care Nurses (ACCCN). It is a bi-monthly peer-reviewed journal, providing clinically relevant research, reviews and articles of interest to the critical care community. Australian Critical Care publishes peer-reviewed scholarly papers that report research findings, research-based reviews, discussion papers and commentaries which are of interest to an international readership of critical care practitioners, educators, administrators and researchers. Interprofessional articles are welcomed.